| Afrin Mustafa Farooq, MD | |
|
199 Reedsdale Rd, Milton, MA 02186-3926 | |
| (617) 754-0748 | |
| (617) 754-0701 |
| Full Name | Afrin Mustafa Farooq |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 199 Reedsdale Rd, Milton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407168065 | NPI | - | NPPES |
| 03617190 | Medicaid | NY | |
| 01131126/RGH | Medicaid | NY | |
| 03007063/NWK | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 270468 (New York) | Primary |
| 207R00000X | Internal Medicine | 270468 (New York) | Secondary |
| 207R00000X | Internal Medicine | 258012 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nvna And Hospice | Norwell, MA | Home health agency |
| Caretenders | Needham heights, MA | Home health agency |
| Partners Healthcare At Home - Home Care | Waltham, MA | Home health agency |
| Visiting Nurse Association Of Boston | Dorchester, MA | Home health agency |
| South Shore Visiting Nurse Association | Rockland, MA | Home health agency |
| Nvna And Hospice | Norwell, MA | Hospice |
| Beth Israel Deaconess Hospital - Milton | Milton, MA | Hospital |
| South Shore Hospital | South weymouth, MA | Hospital |
| Faulkner Hospital-brigham And Women's | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Shore Internal Medicine Associates Inc. | 8820066186 | 12 |
News Archive
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
The research looked at XPB helicase from an archaea, a single cell organism similar to bacteria. Helicases are enzymes that unwind or separate the strands of the nucleic acid double helix, an action that is critical to transcription and nucleotide excision repair (NER), as well as other cell processes.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
This post in the Malaria Policy Center blog recaps a Tuesday Capitol Hill briefing, hosted by Senators Chris Coons (D-Del.) and Roger Wicker (R-Miss.), co-chairs of the Senate Working Group on Malaria, "that highlighted research and development advancements by the U.S. military and U.S. academic institutions to develop the tools to eliminate malaria and keep our servicemen and women safe as they serve overseas."
› Verified 8 days ago
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194765438 PECOS PAC ID: 4486567104 Enrollment ID: O20031204000918 |
News Archive
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
The research looked at XPB helicase from an archaea, a single cell organism similar to bacteria. Helicases are enzymes that unwind or separate the strands of the nucleic acid double helix, an action that is critical to transcription and nucleotide excision repair (NER), as well as other cell processes.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
This post in the Malaria Policy Center blog recaps a Tuesday Capitol Hill briefing, hosted by Senators Chris Coons (D-Del.) and Roger Wicker (R-Miss.), co-chairs of the Senate Working Group on Malaria, "that highlighted research and development advancements by the U.S. military and U.S. academic institutions to develop the tools to eliminate malaria and keep our servicemen and women safe as they serve overseas."
› Verified 8 days ago
| Entity Name | South Shore Internal Medicine Associates Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053475012 PECOS PAC ID: 8820066186 Enrollment ID: O20040923000817 |
News Archive
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
The research looked at XPB helicase from an archaea, a single cell organism similar to bacteria. Helicases are enzymes that unwind or separate the strands of the nucleic acid double helix, an action that is critical to transcription and nucleotide excision repair (NER), as well as other cell processes.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
This post in the Malaria Policy Center blog recaps a Tuesday Capitol Hill briefing, hosted by Senators Chris Coons (D-Del.) and Roger Wicker (R-Miss.), co-chairs of the Senate Working Group on Malaria, "that highlighted research and development advancements by the U.S. military and U.S. academic institutions to develop the tools to eliminate malaria and keep our servicemen and women safe as they serve overseas."
› Verified 8 days ago
| Entity Name | Associated Physicians Of Harvard Medical Faculty Physicians At Beth Is |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497151773 PECOS PAC ID: 6305749987 Enrollment ID: O20150211001099 |
News Archive
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
The research looked at XPB helicase from an archaea, a single cell organism similar to bacteria. Helicases are enzymes that unwind or separate the strands of the nucleic acid double helix, an action that is critical to transcription and nucleotide excision repair (NER), as well as other cell processes.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
This post in the Malaria Policy Center blog recaps a Tuesday Capitol Hill briefing, hosted by Senators Chris Coons (D-Del.) and Roger Wicker (R-Miss.), co-chairs of the Senate Working Group on Malaria, "that highlighted research and development advancements by the U.S. military and U.S. academic institutions to develop the tools to eliminate malaria and keep our servicemen and women safe as they serve overseas."
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Afrin Mustafa Farooq, MD 199 Reedsdale Rd, Milton, MA 02186-3926 Ph: (617) 754-0748 | Afrin Mustafa Farooq, MD 199 Reedsdale Rd, Milton, MA 02186-3926 Ph: (617) 754-0748 |
News Archive
OSI Pharmaceuticals, Inc. today confirmed that Astellas Pharma Inc. has commenced an unsolicited tender offer to acquire all outstanding common shares of OSI for $52.00 per share in cash.
The research looked at XPB helicase from an archaea, a single cell organism similar to bacteria. Helicases are enzymes that unwind or separate the strands of the nucleic acid double helix, an action that is critical to transcription and nucleotide excision repair (NER), as well as other cell processes.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.
This post in the Malaria Policy Center blog recaps a Tuesday Capitol Hill briefing, hosted by Senators Chris Coons (D-Del.) and Roger Wicker (R-Miss.), co-chairs of the Senate Working Group on Malaria, "that highlighted research and development advancements by the U.S. military and U.S. academic institutions to develop the tools to eliminate malaria and keep our servicemen and women safe as they serve overseas."
› Verified 8 days ago
Sara Mohammed, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-313-1377 Fax: 617-754-8632 | |
Hans Chiang, MD, MBA, MS Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-313-1377 | |
Dr. Marzio Napolitano, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-313-1377 | |
Bonnie Cao, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 199 Reedsdale Rd, Milton, MA 02186 Phone: 617-696-4600 | |
Dr. Saifullah Muhammad Shahid, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 199 Reedsdale Road, Milton, MA 02186 Phone: 617-696-4600 |